Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2017/0183336 SWEET FLAVOR MODIFIER
The present invention includes compounds having structural formula (Ia): ##STR00001## or salts or solvates thereof. These compounds are useful as sweet flavor...
2017/0183335 MOLECULES HAVING CERTAIN PESTICIDAL UTILITIES, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES RELATED THERETO
This disclosure relates to the field of molecules having pesticidal utility against pests in phyla Nematoda, Arthropoda, and/or Mollusca, processes to produce...
2017/0183334 DASATINIB SALTS
The invention relates to normal or acidic salts of dasatinib and the hydrate and solvate forms thereof. More specifically the invention concerns: dasatinib...
2017/0183333 DERIVATIVES OF N-(ARYLAMINO) SULFONAMIDES AS INHIBITORS OF MEK
This invention concerns N-(2-arylamino) aryl sulfonamides, which are inhibitors of MEK and are useful in treatment of cancer and other hyperproliferative...
2017/0183332 HETEROCYCLIC AMIDES AS KINASE INHIBITORS
Disclosed are compounds having the formula: ##STR00001## wherein X, Y, Z.sup.1, Z.sup.2, Z.sup.3, Z.sup.4, R.sup.5, R.sup.A, m, A. L, and B are as defined...
2017/0183331 TETRAHYDROQUINOLINE SULFONAMIDE AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORy AND THE TREATMENT OF DISEASE
The invention provides tetrahydroquinoline sulfonamide compounds, tetrahydronaphthalene sulfonyl compounds, and related compounds, pharmaceutical compositions,...
2017/0183330 BENZIMIDAZOLE DERIVATIVES AS ERBB TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CANCER
Provided herein are benzimidazole derivatives, for example, of Formula I, and pharmaceutical compositions thereof. Also provided herein are methods of their...
2017/0183329 PYRIDONE DERIVATIVE HAVING TETRAHYDROPYRANYLMETHYL GROUP
The present disclosure provides novel compounds or salts thereof, or crystals of the compounds or the salts, which inhibit Axl and are useful in the treatment...
2017/0183328 SUBSTITUTED 3-AZABICYCLO[3.1.0]HEXANES AS KETOHEXOKINASE INHIBITORS
Provided herein are substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors, processes to make said compounds, and methods comprising administering...
2017/0183326 COCRYSTAL, PRODUCTION METHOD THEREOF, AND MEDICAMENT CONTAINING COCRYSTAL
The present invention provides a cocrystal of (S)-3-(1-((1-acryloylpyrrolidin-3-yl)oxy)isoquinolin-3-yl)-1H-1,2,4-triaz- ol-5(4H)-one and an organic acid...
2017/0183325 HISTONE DEMETHYLASE INHIBITORS
The present disclosure relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted pyridine...
2017/0183324 MACROCYCLIC PICOLINAMIDES COMPOUNDS WITH FUNGICIDAL ACTIVITY
The invention relates to compounds of macrocyclic picolinamides of Formula I suitable to control or prevent growth of fungi. ##STR00001##
2017/0183323 A NEW METHOD FOR PRODUCING NEBIVOLOL HYDROCHLORIDE OF HIGH PURITY
The invention relates to a process for producing Nebivolol hydrochloride, (formula I) comprising the steps of: provision of a protected Nebivolol hydrochloride...
2017/0183322 COMBINED LEVULINIC ACID AND FURFURAL PRODUCTION FROM BIOMASS RELATED APPLICATION
A process is provided for improved levulinic acid production form biomass, wherein furfural is recovered from vapor flow from the levulinic acid production...
2017/0183321 Selective process for conversion of levulinic acid to gammavalerolactone
A process is disclosed for converting levulinic acid to gammavalerolactone with increased selectivity. The process is based on the recognition of the reaction...
2017/0183320 METHOD OF PREPARING DIAMINOPHENOTHIAZINIUM
Disclosed herein are methods for preparing ultrapure diaminophenothiasinium compounds with high solubility in solutions, e.g., water, and the compositions...
2017/0183319 HUMAN ANDROGEN RECEPTOR DNA-BINDING DOMAN (DBD) COMPOUNDS AS THERAPEUTICS AND METHODS FOR THEIR USE
A compound having the structure of Formula I, wherein A is a substituted or unsubstituted aryl or heteroaryl group, D is a substituted or unsubstituted 5- or...
2017/0183318 AMIDE COMPOUNDS, METHODS FOR PREPARATION, AND USE THEREOF AS AGENTS FOR THE TREATMENT AND PREVENTION OF...
The present invention relates to medicine and includes a method for preventing and treating diseases caused by RNA- and DNA-containing viruses, and concomitant...
2017/0183317 PROCESS FOR THE PREPARATION OF A FLUOROLACTION DERIVATIVE
A novel process for the preparation of a fluorolactone derivative of the formula ##STR00001## and of its acylated derivative of formula ##STR00002## wherein...
2017/0183316 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS
Chemical entities based on quinoxaline that are kinase inhibitors are described. Specifically quinoxaline derivatives of Formula I, containing a diarylamide or...
2017/0183315 SELECTIVE INHIBITORS INTERFERING WITH FIBROBLAST GROWTH FACTOR RECEPTOR AND FRS2 INTERACTION FOR THE PREVENTION...
The present technology relates to medicine and includes the use of inhibitors which selectively interfere with the interaction between a fibroblast growth...
2017/0183313 BICYCLIC HETEROCYCLES CAPABLE OF MODULATING T-CELL RESPONSES, AND METHODS OF USING SAME
The present disclosure is directed in part to bicyclic heterocycles, such as a compound represented by formula (I) or (II) as disclosed herein, and their use...
2017/0183312 HERBICIDAL SUBSTITUTED 3-ARYLPYRAZOLES
Disclosed are compounds of Formula 1, including all stereoisomers, N-oxides, and salts thereof, ##STR00001## wherein X.sup.1, X.sup.2, X.sup.3, G and Q are as...
2017/0183311 THERAPEUTIC COMPOUNDS AND COMPOSITIONS
Compounds and compositions comprising compounds that modulate pyruvate kinase M2 (PKM2) are described herein. Also described herein are methods of using the...
2017/0183310 Form A of Mesylate for Nicotinamide Derivatives and Preparation Method and Application Thereof
The invention discloses a form A of mesylate for nicotinamide derivatives and preparation method and application thereof, wherein the XRPD pattern of the form...
2017/0183309 COMPOUNDS FOR INHIBITION OF FUNGAL TOXIN PRODUCTION
The invention relates to compounds, compositions, and methods that can inhibit the biosynthesis of mycotoxins.
2017/0183308 LSD1 Inhibitors
The present invention relates to compounds that inhibit LSD1 activity. In particular, the present invention relates to compounds, pharmaceutical compositions...
2017/0183307 METHOD FOR PRODUCING SYNTHETIC PENTAPEPTIDE
Provided are a method for industrially advantageously producing a highly purified pentapeptide and an intermediate thereof. A compound represented by the following...
2017/0183306 CYCLIC COMPOUNDS HAVING A 1,3 DIAMINO-FUNCTIONALITY FOR USE IN THE TREATMENT OF HIV INFECTION
The present invention relates to compounds, capable of activating HIV expression in reservoir cells, of formula (I) for use in the treatment of HIV infection. ...
2017/0183305 NOVEL COMPOUNDS AS ANTI-TUBERCULAR AGENTS
The present invention relates to novel compounds of formula (1): The present invention also discloses compounds of formula (1) along with other pharmaceutical...
2017/0183304 LIGHT ABSORPTIVE COMPOUND, POLYMER COMPOSITION CONTAINING THE COMPOUND, POLYMER FILM, AND CURED LAYER
The object of the present invention is to provide a light absorptive compound which is capable of selectively absorbing light around a wavelength of 400 nm,...
2017/0183303 SUBSTITUTED N-ACETYL-L-CYSTEINE DERIVATIVES AND RELATED COMPOUNDS
Novel substituted N-acetyl-L-cysteine (NAC) derivatives and related compounds and methods of using these compounds for the treatment of diseases and/or...
2017/0183302 Method for Preparation of N-Acetyl Cysteine Amide
The present application discloses an efficient process for the preparation of N-acetyl-L-cysteine amide (NACA) starting with N-acetyl-L-cysteine.
2017/0183301 MIXED DECYL MERCAPTANS COMPOSITIONS AND METHODS OF MAKING SAME
Compositions comprising branched C.sub.10 mercaptans selected from the group consisting of 5-methyl-1-mercapto-nonane, 3-propyl-1-mercapto-heptane,...
2017/0183300 THROMBOXANE RECEPTOR ANTAGONISTS
The invention generally relates to compounds that function as TP antagonists for treating thrombosis and other cardiovascular, renal, or pulmonary diseases. In...
2017/0183299 PROCESS FOR PREPARING GUANIDINO-FUNCTIONAL MONOMERS
A process for preparing guanidino-functional, free radically polymerizable compounds comprises (a) combining (1) an amine compound comprising (i) at least one...
2017/0183298 CARBAMOYL HYDRAZINE DERIVATIVES AS FORMYL PEPTIDE MODULATORS
The present invention relates to carbamoyl hydrazine derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as...
2017/0183297 OMEGA-3 ANALOGUES
The present invention relates to new omega-3 fatty acid analogues and to their use in cancer therapy, including anti-metastatic therapy.
2017/0183296 CRYSTALLINE FORM OF y-AMINOBUTYRIC ACID ANALOG
A crystalline form of a .gamma.-aminobutyric acid analog, and methods of preparing same, are provided.
2017/0183295 CYANATED PERYLENE COMPOUNDS
The present invention relates to a cyanated perylene compound of the formula I ##STR00001## in which one of the Z substituents and one of the Z* substituents...
2017/0183294 COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING TUMORS
Disclosed herein are compounds, compositions and methods for treating tumors, particularly tumors that metastasize, via inhibiting tumor cells-induced platelet...
2017/0183293 NOVEL EP4 AGONISTS AS THERAPEUTIC COMPOUNDS
Described herein are compounds that are EP.sub.4 agonists and antagonists which are useful for treating a variety of pathological conditions associated with...
2017/0183292 A PROCESS FOR PREPARATION OF LEVOTHYROXINE AND SALTS THEREOF
The present invention relates to a process for the preparation of Levothyroxine and salts thereof. The process described in the present invention provides...
2017/0183291 NOVEL COMPOUND
A compound is represented by the following formula (1). In the formula (1), Ar is a substituted or unsubstituted aryl group including 6 to 30 ring carbon...
2017/0183290 RESVERATROL ESTERS
A resveratrol ester has the following structure: ##STR00001## R.sup.1, R.sup.2 and R.sup.3 are H or ##STR00002## Each R.sup.4 is independently a carbon chain of 2...
2017/0183289 Terminally Selective Metathesis of Polyenes Derived from Natural Oil
Methods of carrying out metathesis reactions of natural oil-derived polyenes (e.g., dienes and trienes), including functionalized polyenes, are generally...
2017/0183288 METHOD FOR PREPARING HYDROXYETHYL (METH) ACRYLATE
Hydroxyethyl (methyl)acrylate is prepared by a process of a combination of a three-stage tubular reactor and a tower reactor, wherein, firstly, a catalyst, a...
2017/0183287 PREPARATION METHOD OF 1-PALMITOYL-3-ACETYLGLYCEROL, AND PREPARATION METHOD OF...
Disclosed are a method for preparing 1-palmitoyl-3-acetylglycerol in high purity and high yield without a purification process using a column chromatography,...
2017/0183286 POLYMERIZABLE LIQUID CRYSTAL COMPOUND, COMPOSITION FOR OPTICAL FILM, AND OPTICAL FILM, COMPENSATION FILM,...
A polymerizable liquid crystal compound represented by Chemical Formula 1: ##STR00001## wherein in Chemical Formula 1, groups and variables are the same as ...
2017/0183285 SOLVENT EXCHANGER AND METHOD FOR IMPROVING THE EXCHANGE EFFICIENCY OF CTA SOLVENT
A solvent exchanger and a method is provided for: pressurizing a CTA slurry into a solvent exchanger for separation and obtaining a mother liquor, a bias flow...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.